Status and phase
Conditions
Treatments
About
Fibromyalgia and migraine are diseases with high prevalence in women between the age group of 30-60 years, which seem to share the same pathophysiological mechanism; both originate from neuroendocrine disorders of the hypothalamic-pituitary axis in the central nervous system, and are therefore closely related. In addition to the strong relationship with migraine, fibromyalgia can also be associated with sleep disorders, chronic fatigue and psychological disorders. The combination of these factors decreases the quality of life and contributes to increased sedentary this population. It is known that physical exercise promotes positive changes in pain pathophysiological pathway to increase the release of endorphins neuroendógenas, improving the symptoms of fibromyalgia.
The objective of this study is to analyze whether the application of an aerobic exercise program may result in the reduction of the frequency, duration and intensity of migraine attacks in women with fibromyalgia. For this, a clinical trial will be conducted randomized double-blind clinical trial comparing two groups of women diagnosed with fibromyalgia and migraine. Initially, all answer questionnaires assessing quality of life, impact of headache, level of depression and anxiety, sleep quality, physical activity level, and; will be held ergospirometry for research in exercise tolerance. The experimental group will implement the protocol consists of heating, aerobic exercise according to the heart rate established for training by spirometry and slowdown; and the control group will hold the heat on low speed and heart rate will next baseline. Both groups will be followed for 12 weeks, with a frequency of three weekly meetings lasting 30 minutes and re-evaluated every 4 weeks. At the end of the protocol, the groups will have their results were compared and statistically analyzed.
Full description
This study is classified as a randomized double-blind clinical trial. Will be held in the Department of Physiotherapy of the university clinic of the Federal University of Pernambuco, located in University City, Recife-PE. Data for the survey will be collected during the course of the Masters in Physiotherapy, from April 2015 to September 2015, for further analysis.
The analyzed groups shall consist of women aged 30-50 years referred to the Department of Physical Therapy - UFPE, with clinical diagnosis of fibromyalgia and migraine performed by doctors of Rheumatology clinics and Neurology, Hospital das Clinicas, UFPE. Being invited to participate and informed about its content, saying their participation by signing a Term of Consent. Data collection is in accordance with the Declaration of Helsinki, and will begin after the project was approved by the Ethics Committee for Research on Human beings of the Federal University Health Sciences Center of Pernambuco, in accordance with Resolution 466/2012 of the National Research Ethics Committee of the Ministry of Health, the body that regulates research involving human subjects. The study will be registered in the digital Clinical Trials platform after obtaining the registration number of the Ethics Committee. Initially there will be a pilot study with 20 women, then the results will be used to calculate the sample size using the G Power (version 3.1.9.2, Germany), considering a statistical power (β) of 80% with a significance level (α) of 5%.
Will be excluded those that have some other rheumatologic disease, cardio-respiratory or cardiovascular that prevents the realization of aerobic exercise protocol; low attendance during the implementation of the exercise program (over three consecutive absences); cognitive impairment or neurological disease that compromises the understanding and the exercises; Body mass index ≥ 30.0 (obesity, according to the World Society of Health); pregnant women and patients classified as level of active or very active physical activity by IPAQ (International Physical Activity Questionnaire).
3.1. Randomization
Initially, patients will undergo will a simple randomization through the site www.randomization.com, resulting in two groups:
Randomization will be performed by an examiner A, not research participant to ensure allocation concealment (patients and principal investigator will not be aware of which group are allocated). All women will be evaluated (both groups) through questionnaires and spirometry before the start and the end of the exercise protocol. Every four weeks, the patients will be submitted to revaluations through the questionnaires. The evaluation of these volunteers will be conducted by an examiner B (principal investigator), blinded to randomization; and the exercise protocol implementation will be the responsibility of the examiner C, only one will know to which group the patients belong. Corroborating the double-blinding, the evaluator to perform statistical analysis of the data will not know to which group belongs the results.
3.2. Evaluation
The responses to the cardiopulmonary exercise testing (CPX) are obtained by means of an incremental protocol, which consists in progressive load increases at predetermined time periods. A typical incremental protocol should provide: a resting phase (2-3 minutes or more), in which we observe a lack of hyperventilation before starting the test; a heating period with zero charge (2-3 minutes); incrementing a time (8-12 minutes) and an active period of recovery with no load (3-6 minutes if possible). For the intervention protocol, heart rate obtained just below the anaerobic threshold, recommended for proper intensity to gain fitness with greater security and compliance will be used. Generally, oxygen consumption levels in the anaerobic threshold are lower in these patients.
-Re-Reviews Initially, will be held the evaluation of patients through questionnaires and cardiopulmonary stress test to investigate exercise tolerance before the start of exercise protocol (review 1). Every 4 weeks, the patients of both groups will be reassessed by the re-application of all questionnaires: 4 weeks - review 2; 8 weeks: evaluation 3. At the end of the 12 weeks of training, the review 4 will be held, with repetition of the questionnaires and cardiopulmonary exercise testing.
3.3. Intervention protocol The intervention protocol will be made by the examiner C, one who is not blind to the research. After randomization and evaluation, patients will be allocated to one of the groups: experimental or control. After the evaluation of cardiorespiratory capacity of patients, will be established starting parameters appropriate to the level of physical activity each based on heart rate obtained just below the anaerobic threshold (ensuring aerobic work).
The experimental group will follow the following protocol: performing heating for 5 minutes at low speed on a treadmill; after heating, the speed is increased gradually until the patient reaches the proper heart rate for aerobic training obtained during cardiopulmonary exercise testing, maintaining the same for 20 minutes to perform the aerobic workout; completed, the velocity will be decreased to regain speed heating maintained for 5 minutes and finishing training. It is envisaged that in practice using the FC to ensure proper aerobic exercise for 20-60 minutes at a frequency of 3-5 times per week are effective in increasing the functional capacity of individuals with low fitness (American College of Sports Medicine - ACSM, 2006). In the control group, these women will be guided to perform 10 minutes of heating on the treadmill with a low speed that does not cause patient effort (monitored by the Borg scale and FC close to the basement).
Both groups will be followed for 12 weeks, with a driving frequency of 3 times per week. Heart rate and saturation of peripheral oxygen (SpO2) will be continuously monitored through the use of finger pulse oximeter during the course of all practices of all the volunteers of research to ensure that HR is within the established for each group
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Loading...
Central trial contact
Manuella MB Barros, Master; Daniella A Oliveira, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal